Covenant High Plains Surgery Center completes 100th Inspire® Therapy Procedure
CHPSC is the top-rated ambulatory surgery center in
The Inspire procedure is a natural fit for CHPSC as an advanced, effective treatment for OSA, which affects 22 million Americans and impacts both the patient and everyone around them. OSA can cause vehicle and workplace accidents, worsening mood and memory, stroke, heart attack, and other serious issues.
CPAP is the main treatment for OSA, but many do not benefit from or cannot tolerate CPAP. Inspire works inside the body with a patient's natural breathing process to treat sleep apnea. Mild stimulation opens the airway during sleep, allowing oxygen to flow naturally. The patient uses a small handheld remote to turn Inspire on before bed and off when they wake up.
The Inspire system is implanted during a short, outpatient procedure. The system is placed under the skin of the neck and chest through two small incisions. CHPSC patients return home the same day and take over-the-counter pain medications to manage pain as needed.
"I'm excited to have completed our 100th Inspire procedure at Covenant High Plains Surgery Center," said
About Covenant High Plains Surgery Center, LLC
CHPSC operates two freestanding, independent multispecialty ambulatory surgery centers (ASCs) in
View original content:https://www.prnewswire.com/news-releases/covenant-high-plains-surgery-center-completes-100th-inspire-therapy-procedure-302285963.html
SOURCE Covenant High Plains Surgery Center
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tanager 2 Launch to Scale Up Carbon Mapper's Methane Impact
- Linea Energy Closes Project Debt Financing and Preferred Equity Commitment for 250 MW / 500 MWh Mesa View BESS in Texas
- THE FREDERICK ARTS COUNCIL AND YMCA AUSHERMAN ARTS CENTER ANNOUNCE CALL FOR ARTISTS FOR WINTER ARTIST MARKET
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share